Homegrown candidate vaccine Covivac begins second stage of clinical trials

Vietnam’s second homegrown candidate vaccine Covivac began the second stage of clinical trials in the northern province of Thai Binh’s Vu Thu district on August 11 with the screening testing to choose qualified volunteers.
Homegrown candidate vaccine Covivac begins second stage of clinical trials ảnh 1Vietnam’s second homegrown candidate vaccine Covivac (Photo: VNA)
Hanoi (VNA) - Vietnam’s second homegrown candidate vaccine Covivac beganthe second stage of clinical trials in the northern province of Thai Binh’s VuThu district on August 11 with the screening testing to choose qualifiedvolunteers.

The screening testing will be conducted for six days, and thefirst jabs are expected to be given on August 18.

A total of 375 volunteers, chosen from 750 local residentsin Vu Thu district, will be classified in three groups for the 3mcg and 6 mcgdosages and injections of vaccine AstraZeneca (instead of placebo infections inthe first phase).

Earlier, assessing the first stage of Covivac human trialson over 120 volunteers since March 15, the National Ethics Committee inBiomedical Research under the Ministry of Health concluded that the vaccine wassafe, well tolerated, immunogenic, and eligible for the second stage.

Covivac has been developed and produced by the Institute of Vaccines and Medical Biologicals (IVAC). Ituses primary chicken embryo cell culture - a technique the institute usedpreviously to successfully produce seasonal flu vaccines.

Associate Professor, Dr. Vu Dinh Thiem, director of theNIHE’s clinical trial center, said that the selected volunteers must be over 18years old, possibly up to 70-80 years old, including those with chronicdiseases such as diabetes, hypertension but under stable treatment.

If the second stage goes well, by the end of September, theresearch team will collect blood samples from the volunteers on the 42nd dayafter their first jabs to evaluate the vaccine’s immunogenicity.

On the 57th day, the volunteers will continue to undergophysical examination and take blood tests for evaluation and analysis beforethe team proposes the third stage of trials on 1,000 volunteers./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.

PM Pham Minh Chinh (second from right) visits the Karolinska Institutet. (Photo: VNA)

PM seeks stronger medical ties with Sweden’s Karolinska Institutet

The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.

D.F (left), a US patient, at a follow-up examination with Do Lenh Hung, head of the department of urethral reconstructive surgery. (Photo: VNA)

High-quality healthcare services attract more foreign patients to Binh Dan Hospital

Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T

A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.

On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.